Journal of Gastroenterology

Papers
(The TQCC of Journal of Gastroenterology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom181
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis97
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study86
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy81
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv66
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease61
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy56
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus56
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy55
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis51
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism49
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts48
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers44
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma42
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma40
Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan34
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data32
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery32
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database31
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy31
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis30
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials30
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan29
Hic-5 deficiency attenuates MAFLD by inhibiting neutrophils migration via the CXCL1-CXCR2 axis29
Successful induction of human chemically induced liver progenitors with small molecules from damaged liver29
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial29
Clinical practice guidelines for duodenal cancer 202129
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study28
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices28
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis26
Acknowledgements25
Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan25
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey25
Current status and trends in ERCP and post-ERCP pancreatitis in Japan: a nationwide observational study24
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?24
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation24
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan24
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis23
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan23
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 202122
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)22
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime21
A study for every second day administration of vonoprazan for maintenance treatment of erosive GERD (ESD von GERD): a multicenter randomized cross-over study21
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma21
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia21
Is it necessary for endoscopic surveillance for achalasia patients?21
Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study20
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study20
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials20
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection19
Targeting autophagy as a therapeutic strategy against pancreatic cancer19
Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-1919
Reply to “Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data”19
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer18
Clinicopathological features and prognosis of metastatic tumors in the small bowel: a large multicenter analysis of the JSCCR database in Japan18
Gastric cancer and genomics: review of literature17
Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)17
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases17
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?17
VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathway17
Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”16
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society16
Correction: Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multic16
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma16
Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases16
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)16
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis15
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry15
Molecular imaging of gastrointestinal stromal tumor using anti-c-KIT antibody and its fragments15
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention14
Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912)14
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development14
Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn’s disease in Japan in 202314
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia14
AI-assisted diagnosis of Helicobacter pylori infection: strengths, limitations, and future directions14
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease14
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation14
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy14
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando13
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data13
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer13
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis13
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan13
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance13
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy13
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia13
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY12
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance12
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study12
Renal manifestations in inflammatory bowel disease: a systematic review12
Validation of novel scoring systems for acute decompensated cirrhosis identifies PBC as an independent poor prognostic factor: a single-center Japanese cohort study12
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy12
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation12
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study12
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation12
Acknowledgements12
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease11
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis11
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis11
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia11
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co11
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”11
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy11
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia11
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer11
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study11
Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients11
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer11
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma11
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors10
The antiferroptotic effect of indigo on ulcerative colitis10
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer10
Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach9
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer9
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy9
Acknowledgements9
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease9
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis9
Cost–utility analysis of treatment strategies for chronic constipation in Japan9
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study9
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection9
Current status of type 1 (IgG4-related) autoimmune pancreatitis9
Growing evidence on the highly sensitive iTACT assay of hepatitis B core-related antigen for predicting hepatitis B virus reactivation9
Single-cell transcriptomics reveals hypoxia-driven iCAF_PLAU is associated with stemness and immunosuppression in anorectal malignant melanoma9
Predictors of lymph node metastases, recurrence, and survival in patients with pedunculated-type T1 colorectal cancer9
Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990–2019: a decomposition and age–period–cohort analysis9
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway9
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma9
Letter to "The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trial"9
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”9
Clarifying diagnostic scope and future perspectives in AI-assisted diagnosis of Helicobacter pylori infection9
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenoc9
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus9
0.28120708465576